The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies

av Skarbnik, Alan P., Faderl, Stefan
I publikationen Ther Adv Hematol (2016)

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia

av Koprivnikar, Jamie, McCloskey, James, Faderl, Stefan
I publikationen Onco Targets Ther (2017)

Hematologic malignancies acute leukemias /

av Estey, Elihu H., Faderl, Stefan H., Kantarjian, Hagop M.
Publicerad 2008.

Long-Term Follow-up of Patients With Hypereosinophilic Syndrome Treated With Alemtuzumab, an Anti-CD52 Antibody

av Strati, Paolo, Cortes, Jorge, Faderl, Stefan, Kantarjian, Hagop, Verstovsek, Srdan
I publikationen Clin Lymphoma Myeloma Leuk (2012)

Results of the Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Regimen in Elderly Patients With Acute Lymphocytic Leukemia

av O’Brien, Susan, Thomas, Deborah A., Ravandi, Farhad, Faderl, Stefan, Pierce, Sherry, Kantarjian, Hagop
Publicerad 2008

Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence

av Faderl, Stefan, Ferrajoli, Alessandra, Wierda, William, O'Brien, Susan, Lerner, Susan, Keating, Michael J.
I publikationen Cancer (2010)

Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years

av Faderl, Stefan, Wierda, William, O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan, Keating, Michael J.
I publikationen Leuk Res (2009)

Is Acute Myeloid Leukemia a Liquid Tumor?

av Ohanian, Maro, Faderl, Stefan, Ravandi, Farhad, Pemmaraju, Naveen, Garcia-Manero, Guillermo, Cortes, Jorge, Estrov, Zeev
Publicerad 2013

Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience

av Vega-Ruiz, Arturo, Faderl, Stefan, Estrov, Zeev, Pierce, Sherry, Cortes, Jorge, Kantarjian, Hagop, Ravandi, Farhad
Publicerad 2009

A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities

av Chen, Yiming, Kantarjian, Hagop, Estrov, Zeev, Faderl, Stefan, Ravandi, Farhad, Rey, Kristy, Cortes, Jorge, Borthakur, Gautam
Publicerad 2012

Fludarabine, cyclophosphamide, and rituximab (FCR) plus GM-CSF as frontline treatment for patients with Chronic Lymphocytic Leukemia

av Strati, Paolo, Ferrajoli, Alessandra, Lerner, Susan, O’Brien, Susan, Wierda, William, Keating, Michael J, Faderl, Stefan
I publikationen Leuk Lymphoma (2013)

The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up

av Garg, Ravin J., Kantarjian, Hagop, O'Brien, Susan, Quintás-Cardama, Alfonso, Faderl, Stefan, Estrov, Zeev, Cortes, Jorge
Publicerad 2009

Adults With Acute Lymphoblastic Leukemia and Translocation (1;19) Abnormality Have a Favorable Outcome With Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexame...

av Garg, Ravin, Kantarjian, Hagop, Thomas, Deborah, Faderl, Stefan, Ravandi, Farhad, Lovshe, Denise, Pierce, Sherry, O’Brien, Susan
Publicerad 2009

Blood counts at time of complete remission provide additional independent prognostic information in acute myeloid leukemia

av Yanada, Masamitsu, Borthakur, Gautam, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, Pierce, Sherry, Kantarjian, Hagop, Estey, Elihu
Publicerad 2008

Incidence of and risk factors for acute myeloid leukemia involvement of the central nervous system

av Rozovski, Uri, Ohanian, Maro, Ravandi, Farhad, Garcia-Manero, Guillermo, Faderl, Stefan, Pierce, Sherry, Cortes, Jorge, Estrov, Zeev
I publikationen Leuk Lymphoma (2014)

Anthracycline Dose Intensification in Adult Acute Lymphoblastic Leukemia: Lack of Benefit in the Context of the Fractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamet...

av Thomas, Deborah, O'Brien, Susan, Faderl, Stefan, Ravandi, Farhad, Jabbour, Elias, Pierce, Sherry, Cortes, Jorge, Kantarjian, Hagop
I publikationen Cancer (2010)

Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia

av Gardner, Alison, Mattiuzzi, Gloria, Faderl, Stefan, Borthakur, Gautam, Garcia-Manero, Guillermo, Pierce, Sherry, Brandt, Mark, Estey, Elihu
I publikationen J Clin Oncol (2008)

Adult Acute Lymphoblastic Leukemia: Concepts and Strategies

av Faderl, Stefan, O’Brien, Susan, Pui, Ching-Hon, Stock, Wendy, Wetzler, Meir, Hoelzer, Dieter, Kantarjian, Hagop M.
I publikationen Cancer (2010)

Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML

av Cortes, Jorge E., Lin, Tara L., Uy, Geoffrey L., Ryan, Robert J., Faderl, Stefan, Lancet, Jeffrey E.
I publikationen J Hematol Oncol (2021)

Very Long-term Follow-Up Results of Imatinib Mesylate Therapy in Chronic Phase Chronic Myeloid Leukemia After Failure of Interferon Alpha Therapy

av Kantarjian, Hagop, O’Brien, Susan, Garcia-Manero, Guillermo, Faderl, Stefan, Ravandi, Farhad, Jabbour, Elias, Shan, Jianqin, Cortes, Jorge
Publicerad 2012